These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15831436

  • 1. P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].
    Teraishi F, Wu S, Sasaki J, Zhang L, Zhu HB, Davis JJ, Fang B.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):355-62. PubMed ID: 15831436
    [Abstract] [Full Text] [Related]

  • 2. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL, Cho CY, Kuo PL, Huang YT, Lin CC.
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [Abstract] [Full Text] [Related]

  • 3. MMPT as a reactive oxygen species generator induces apoptosis via the depletion of intracellular GSH contents in A549 cells.
    Zhao YF, Zhang C, Suo YR.
    Eur J Pharmacol; 2012 Aug 05; 688(1-3):6-13. PubMed ID: 22609960
    [Abstract] [Full Text] [Related]

  • 4. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H, Jiang C, Ip C, Rustum YM, Lü J.
    Clin Cancer Res; 2005 Mar 15; 11(6):2379-88. PubMed ID: 15788689
    [Abstract] [Full Text] [Related]

  • 5. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC.
    Clin Cancer Res; 2003 Jul 15; 9(7):2826-36. PubMed ID: 12855663
    [Abstract] [Full Text] [Related]

  • 6. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 7. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 28; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 8. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 9. Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models.
    Lee CH, Yao CF, Huang SM, Ko S, Tan YH, Lee-Chen GJ, Wang YC.
    Cancer; 2008 Aug 15; 113(4):815-25. PubMed ID: 18618576
    [Abstract] [Full Text] [Related]

  • 10. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells.
    Sakamoto H, Mashima T, Sato S, Hashimoto Y, Yamori T, Tsuruo T.
    Clin Cancer Res; 2001 Aug 15; 7(8):2513-8. PubMed ID: 11489834
    [Abstract] [Full Text] [Related]

  • 11. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.
    Cancer Gene Ther; 2009 Jan 15; 16(1):65-72. PubMed ID: 18654608
    [Abstract] [Full Text] [Related]

  • 12. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.
    Bielak-Mijewska A, Piwocka K, Magalska A, Sikora E.
    Cancer Chemother Pharmacol; 2004 Feb 15; 53(2):179-85. PubMed ID: 14530869
    [Abstract] [Full Text] [Related]

  • 13. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
    Fantappiè O, Solazzo M, Lasagna N, Platini F, Tessitore L, Mazzanti R.
    Cancer Res; 2007 May 15; 67(10):4915-23. PubMed ID: 17510421
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
    Lampiasi N, Azzolina A, D'Alessandro N, Umezawa K, McCubrey JA, Montalto G, Cervello M.
    Mol Pharmacol; 2009 Aug 15; 76(2):290-300. PubMed ID: 19461054
    [Abstract] [Full Text] [Related]

  • 15. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo.
    Hofstetter B, Vuong V, Broggini-Tenzer A, Bodis S, Ciernik IF, Fabbro D, Wartmann M, Folkers G, Pruschy M.
    Clin Cancer Res; 2005 Feb 15; 11(4):1588-96. PubMed ID: 15746064
    [Abstract] [Full Text] [Related]

  • 16. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines.
    Hsiao JR, Leu SF, Huang BM.
    J Oral Pathol Med; 2009 Feb 15; 38(2):188-97. PubMed ID: 19200178
    [Abstract] [Full Text] [Related]

  • 17. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan 15; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 18. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ, Bi H, Feng JQ, Cao JG.
    Acta Pharmacol Sin; 2005 Aug 15; 26(8):1009-16. PubMed ID: 16038636
    [Abstract] [Full Text] [Related]

  • 19. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 20. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J, Chervin AS, Nie A, Ducoff HS, Huang Z.
    Oncogene; 2007 Feb 01; 26(5):652-61. PubMed ID: 16909121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.